Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1477-1480, March 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osborne, M. P.
Right arrow Articles by Telang, N. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osborne, M. P.
Right arrow Articles by Telang, N. T.

Effect of Tamoxifen on Preneoplastic Cell Proliferation in N-Nitroso-N-methylurea-induced Mammary Carcinogenesis1

Michael P. Osborne2, Jeanne F. Ruperto, Joseph P. Crowe, Paul P. Rosen and Nitin T. Telang

Breast Cancer Research Laboratory [M. P. O., J. F. R., J. P. C., N. T. T.] and Department of Pathology [P. P. R.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021

N-Nitroso-N-methylurea (NMU) is an effective carcinogen for the induction of mammary carcinoma in the rat. Tamoxifen (TAM), used as a chemopreventive agent to reduce tumor incidence, has been well studied using this model. We have utilized the rat mammary carcinoma model to assess the effect of TAM on preneoplastic changes. Fifty-day-old virgin female Sprague-Dawley rats were randomized by weight and divided into the following five groups: Group 1, normal controls (n = 24); Group 2, TAM (n = 20); Group 3, NMU-short term (n = 24); Group 4, NMU-short term + TAM (n = 26); and Group 5, NMU-long term (n = 23). Seven weeks after the exposure to NMU, rats in Groups 1, 2, 3, and 4 were given injections of [3H]thymidine and sacrificed 4 h later for autoradiographic determination of thymidine labeling index (TLI). The rats from Group 5 were observed for 30 weeks after NMU exposure to confirm mammary tumor development. TLI in both terminal ducts and terminal end buds was modulated by treatment with TAM. Carcinogen administration induced higher TLI relative to the normal controls [18.3 ± 1.8% (SD) versus 15.5 ± 2.1%, P < 0.001] in terminal end buds. The effect of carcinogen on TLI was also apparent in the terminal ducts (15.8 ± 1.1% versus 9.5 ± 1.1%, P < 0.001). TAM administration was able to suppress both constitutive and NMU-induced TLI increases in terminal end buds (15.5 ± 2.1% versus 2.8 ± 1.1% and 18.3 ± 1.8% versus 6.8 ± 1.4%, respectively, P < 0.001). Similar effects were observed in terminal ducts. In addition to its antiproliferative effect on nontransformed mammary tissue, TAM was effective in suppressing NMU-induced mammary tumor incidence and frequency. NMU-induced hyperproliferation is an intermediate stage in NMU carcinogenesis in the rat and is suppressed by TAM. Mammary epithelial hyperproliferation may provide a useful quantitative intermediate end point to evaluate chemopreventive efficacy.

1 Supported by the Wanda Jablonski Fund and the Claire and Leonard Tow Foundation to M. P. O. and by the NIH Grant R29 CA 44741 to N. T. T.

2 To whom requests for reprints should be addressed, at Strang-Cornell Cancer Research Laboratory, Cornell University Medical College, 428 East 72nd Street, Suite 600, New York, NY 10021.

Received 7/23/91. Accepted 1/ 8/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Murata, S. L. Kominsky, M. Vali, Z. Zhang, E. Garrett-Mayer, D. Korz, D. Huso, S. D. Baker, J. Barber, E. Jaffee, et al.
Ductal Access for Prevention and Therapy of Mammary Tumors
Cancer Res., January 15, 2006; 66(2): 638 - 645.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Shan, M. Yu, H. A.J. Schut, and E. G. Snyderwine
Susceptibility of Rats to Mammary Gland Carcinogenesis by the Food-Derived Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) Varies with Age and Is Associated with the Induction of Differential Gene Expression
Am. J. Pathol., July 1, 2004; 165(1): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Shilkaitis, A. Green, V. Steele, R. Lubet, G. Kelloff, and K. Christov
Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death
Carcinogenesis, February 1, 2000; 21(2): 227 - 233.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. P. OSBORNE
Breast Cancer Prevention by Antiestrogens
Ann. N.Y. Acad. Sci., January 1, 1999; 889(1): 146 - 151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.